Advanced search
Publication Cover
Emerging Microbes & Infections Volume 9, 2020 - Issue 1
Submit an article Journal homepage
3,367
Views
23
CrossRef citations to date
0
Altmetric
Letter

Structural basis of HCoV-19 fusion core and an effective inhibition peptide against virus entry

Huan Suna CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS), Beijing, People’s Republic of ChinaView further author information
,
Yan Lia CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS), Beijing, People’s Republic of ChinaView further author information
,
Peipei Liub NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People’s Republic of ChinaView further author information
,
Chengpeng Qiaoc CAS Key Laboratory of Microbial Physiological and Metabolic Engineering, Institute of Microbiology, Chinese Academy of Sciences, Beijing, People’s Republic of ChinaView further author information
,
Xiaomin Wanga CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS), Beijing, People’s Republic of China;d University of Chinese Academy of Sciences, Beijing, People’s Republic of ChinaView further author information
,
Lianao Wua CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS), Beijing, People’s Republic of China;e Institute of Physical Science and Information, Anhui University, Hefei, People’s Republic of ChinaView further author information
,
Kefang Liua CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS), Beijing, People’s Republic of ChinaView further author information
,
Yu Hua CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS), Beijing, People’s Republic of ChinaView further author information
,
Chao Sua CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS), Beijing, People’s Republic of China;f College of Veterinary Medicine, China Agricultural University, Beijing, People’s Republic of ChinaView further author information
,
Shuguang Tana CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS), Beijing, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0002-2599-4959View further author information
ORCID Icon,
Shumei Zoub NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People’s Republic of ChinaView further author information
,
Guizhen Wub NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People’s Republic of ChinaView further author information
,
Jinghua Yana CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS), Beijing, People’s Republic of China;c CAS Key Laboratory of Microbial Physiological and Metabolic Engineering, Institute of Microbiology, Chinese Academy of Sciences, Beijing, People’s Republic of China;g Savaid Medical School, University of Chinese Academy of Sciences, Beijing, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0003-0502-3829View further author information
ORCID Icon,
George Fu Gaoa CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS), Beijing, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0002-3869-615XView further author information
ORCID Icon,
Jianxun Qia CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS), Beijing, People’s Republic of China;g Savaid Medical School, University of Chinese Academy of Sciences, Beijing, People’s Republic of ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-9358-4732View further author information
ORCID Icon &
Qihui Wanga CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS), Beijing, People’s Republic of China;c CAS Key Laboratory of Microbial Physiological and Metabolic Engineering, Institute of Microbiology, Chinese Academy of Sciences, Beijing, People’s Republic of ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-3768-0401View further author information
ORCID Icon show all
Pages 1238-1241 | Received 27 Mar 2020, Accepted 14 May 2020, Published online: 09 Jun 2020

References

  • Gao GF. From “A”IV to “Z”IKV: attacks from emerging and re-emerging pathogens. Cell. 2018;172(6):1157–1159. doi: 10.1016/j.cell.2018.02.025
  • Jiang S, Shi Z, Shu Y, et al. A distinct name is needed for the new coronavirus. The Lancet. 2020;395(10228):949. doi: 10.1016/S0140-6736(20)30419-0
  • Lu G, Wang Q, Gao GF. Bat-to-human: spike features determining ‘host jump’ of coronaviruses SARS-CoV, MERS-CoV, and beyond. Trends Microbiol. 2015;23(8):468–478. doi: 10.1016/j.tim.2015.06.003
  • Gao J, Lu G, Qi J, et al. Structure of the fusion core and inhibition of fusion by a heptad repeat peptide derived from the S protein of middle east respiratory syndrome coronavirus. J Virol. 2013;87(24):13134–13140. doi: 10.1128/JVI.02433-13
  • Bosch BJ, Martina BE, Van Der Zee R, et al. Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides. Proc Natl Acad Sci USA. 2004;101(22):8455–8460. doi: 10.1073/pnas.0400576101
  • Xu Y, Lou Z, Liu Y, et al. Crystal structure of severe acute respiratory syndrome coronavirus spike protein fusion core. J Biol Chem. 2004;279(47):49414–49419. doi: 10.1074/jbc.M408782200
  • Gao GF. Peptide inhibitors targeting virus-cell fusion in class I enveloped viruses. In: Torrence PF, editor. Combating the threat of pandemic influenza: drug discovery approaches. New York (NY): John Wiley & Sons; 2007. p. 226–246.
  • Sainz B, Mossel EC, Gallaher WR, et al. Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein. Virus Res. 2006;120(1–2):146–155. doi: 10.1016/j.virusres.2006.03.001
  • Lu L, Liu Q, Zhu Y, et al. Structure-based discovery of middle east respiratory syndrome coronavirus fusion inhibitor. Nat Commun. 2014;5:3067. doi: 10.1038/ncomms4067
  • Xia S, Liu M, Wang C, et al. Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion. Cell Res. 2020;30(4):343–355. doi: 10.1038/s41422-020-0305-x

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.